Interleukin 28B gene polymorphisms and epstein-barr virus-associated lymphoproliferative diseases

Intervirology

Volumn 57, Issue 2, 2014, Pages 112-115

  Akay, Ela ^a   Patel, Mauli ^a   Conibear, Tim ^a   Chaggar, Turren ^a   Haque, Tanzina ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Acute infectious mononucleosis; Epstein Barr virus; IL28B gene polymorphisms; Posttransplant lymphoproliferative disease; Viral load

Indexed keywords

GENOMIC DNA; INTERLEUKIN 28B; ALPHA INTERFERON; EPSTEIN BARR VIRUS DNA; INTERLEUKIN 10; UNCLASSIFIED DRUG; VIRUS DNA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; POLYMERASE CHAIN REACTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VIREMIA; ALLELE; CYTOKINE RESPONSE; DNA EXTRACTION; EPSTEIN BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISEASE; HEPATITIS B; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHERITANCE; PROMOTER REGION; VIRAL LOAD TESTING; VIRUS REPLICATION;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPING TECHNIQUES; HUMANS; INFANT; INFECTIOUS MONONUCLEOSIS; INTERLEUKINS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84898597552     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000357326     Document Type: Article

References (14)

1. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB: Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
2. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J: IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy . Nat Genet 2009; 41: 1100-1104.
3. Kotenko SV, Gallagher G, Baurin VV, Lewis- Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP: IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69-77.
4. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63-68.
5. Haque T, Crawford DH: Epstein-Barr virus; in Zuckerman AJ, Banatvala JE, Schoub BD, Griffiths PD, Mortimer P (eds): Principles and Practice of Clinical Virology, ed 6. Chichester, Wiley & Sons, 2009, pp 199-221.
6. McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H, Crawford DH: HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117: 3042-3048.
7. McAulay KA, Haque T, Crawford DH: Tumour necrosis factor gene polymorphism: A predictive factor for the development of posttransplant lymphoproliferative disease. Br J Cancer 2009; 101: 1019-1102.
8. Montes-Cano MA, Garcia-Lozano JR, Abad- Molina C, Romero-Gomez M, Barroso N, Aguilar-Reina J, Nunez-Roldan A, Gonzalez- Escribano MF: Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010; 52: 33-37.
9. Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH: Soluble CD30: A serum marker for Epstein-Barr virus-associated lymphoproliferative diseases. J Med Virol 2011; 83: 311-316.
10. Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL: IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis 2010; 202: 1749-1753.
11. Helminen M, Lahdenpohja N, Hurme M: Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 1999; 180: 496-499.
12. Helminen ME, Kilpinen S, Virta M, Hurme M: Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 2001; 184: 777-780.
13. Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P: Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 2007; 84: 387-391.
14. Thomas RV, McAulay K, Higgins C, Wilkie G, Crawford DH: Interferon gamma (IFNgamma) polymorphism in posttransplantation lymphoproliferative disease. Blood 2005; 106: 1502-1503.